The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 4×
“Similarly, SP burden and distribution allows the classification of SP pathology into stages A (basal neocortex including orbitary and temporal cortices), B (isocortical involvement covering associated cortices), and C (involving in addition the primary cortical areas) (Braak and Braak, 1991; Braak et al., 2006; Ferrer…”
BackgroundInfluentialBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 10×
“Another 16 cases had not suffered from apparent cognitive impairment and dementia but had lesions consistent with ADrelated pathology at postmortem examination (Braak et al., 2006).”
BackgroundInfluentialLinking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972 · cited 3×
“In addition, it seems that membrane lipids may be determinant factors in controlling APP/BACE convergence under pathologic conditions (Abad-Rodriguez et al., 2004; Di Paolo and Kim, 2011; Kaether and Haass, 2004).”
BackgroundDocosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872 · cited 1×
“These fatty acids have the capacity to influence plasma membrane organization and activity of resident proteins by modulating the lipid composition and functionality and thermodynamics of lipid raft domains (Almansa et al., 2003; Shaikh et al., 2003, 2004; Stillwell and Wassall, 2003).”
BackgroundFatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Chan, R. B., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K. E., Small, S. A., Wenk, M. R., Shui, G., & Di Paolo, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274142 · Cited by 630 · cited 4×
“…alterations in AD brains has beenwellestablished in the last years, in particular with reference to cholesterol and polyunsaturated fatty acids contents (Chan et al., 2012; Di Paolo and Kim, 2011; Lutjohann et al., 2000; Prasad et al., 1998; Skinner et al., 1993; Soderberg et al., 1991, 1992).”
BackgroundInfluentialFerrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174 · cited 2×
“…of SP pathology into stages A (basal neocortex including orbitary and temporal cortices), B (isocortical involvement covering associated cortices), and C (involving in addition the primary cortical areas) (Braak and Braak, 1991; Braak et al., 2006; Ferrer, 2012; Serrano-Pozo et al., 2011).”
BackgroundSelf-citationBurke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127 · cited 2×
“…gangliosides, cholesterol, and phospholipids (Matsuzaki, 2007; Matsuzaki and Horikiri, 1999) but also these interactions catalyze conformational changes (random coil to b-sheet) and accelerate fibril formation (Askarova et al., 2011; Burke et al., 2013; Matsuzaki, 2007; Wahlström et al., 2008).”
BackgroundAso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00560.x · Cited by 118
Self-citation
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
The road to restoring neural circuits for the treatment of Alzheimer's disease
Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565
Varma, V. R., Oommen, A. M., Varma, S., Casanova, R., An, Y., Andrews, R. M., O’Brien, R., Pletnikova, O., Troncoso, J. C., Toledo, J., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002482 · Cited by 475
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
Docosahexaenoic Acid and Cognition throughout the Lifespan
Weiser, M., Butt, C., & Mohajeri, M. (2016) · Nutrients · doi:10.3390/nu8020099 · Cited by 400
Wang, R., Li, B., Lam, S. M., & Shui, G. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.009 · Cited by 330
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244
“Numerous studies have shown that alterations in the composition of the brain’s lipid profile and cerebral lipid homeostasis are associated with the disease onset and progression [14–17].”
BackgroundCholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226
Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223
“Lipid raft composition in the frontal and entorhinal cortices is altered even from the earliest stages of AD, accompanied by an accumulation of BACE1 in raft domains [18].”
BackgroundPeng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
Rudajev, V., & Novotny, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937056 · Cited by 94
Díaz, M., Mesa-Herrera, F., & Marín, R. (2021) · Antioxidants · doi:10.3390/antiox10060907 · Cited by 84
Self-citationCao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Membrane raft domains and remodeling in aging brain
Colin, J., Gregory-Pauron, L., Lanhers, M.-C., Claudepierre, T., Corbier, C., Yen, F. T., Malaplate-Armand, C., & Oster, T. (2016) · Biochimie · doi:10.1016/j.biochi.2016.08.014 · Cited by 55
Bai, X., Mai, M., Yao, K., Zhang, M., Huang, Y., Zhang, W., Guo, X., Xu, Y., Zhang, Y., Qurban, A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01338-3 · Cited by 51
Cho, Y. Y., Kwon, O.-H., Park, M. K., Kim, T.-W., & Chung, S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210535 · Cited by 48
Villamil-Ortiz, J. G., Barrera-Ocampo, A., Arias-Londoño, J. D., Villegas, A., Lopera, F., & Cardona-Gómez, G. P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170554 · Cited by 24
Metadata
- Authors
- Fabelo, N., Martín, V., Marín, R., Moreno, D., Ferrer, I., & Díaz, M.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 35
- Issue
- 8
- Pages
- 1801-1812
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W1972930653
- Cited by
- 163
- References
- 10
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.